Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 Mar;20(1):111-3.
doi: 10.1016/j.jcrc.2004.08.009.

Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome

Hesham A Hassaballa  1 , Omar B Lateef, Michael R Silver, Robert A Balk
Affiliations
Case Reports

Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome

Hesham A Hassaballa et al. J Crit Care. 2005 Mar.

Abstract

Arsenic trioxide has been used successfully for the treatment of refractory acute promyelocytic leukemia and has shown promise in the treatment of myelodysplastic syndrome (MDS), although it is not a labeled indication. Retinoic acid syndrome is manifested by fever, dyspnea, peripheral edema, pulmonary infiltrates, and pleural and/or pericardial effusions and is typically seen in conjunction with all- trans retinoic acid therapy of acute promyelocytic leukemia. We report a case of acute lung injury and a retinoic acid syndrome-like illness in a patient who received arsenic for MDS. To our knowledge, this is the first such report, and clinicians should be aware of this potentially life-threatening complication of arsenic trioxide treatment in patients with MDS.

PubMed Disclaimer

Publication types